GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Nanoscale Encasement and Targeted Delivery of Multifunctional Therapeutic Agents

$514,683
Thomas V O'Halloran · Northwestern University At Chicago · U54 · FY2009 · CA

Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer

$514,572
Kathryn L Penney · Brigham And Women'S Hospital · R37 · FY2022 · CA

Effector T Cell Trafficking in Ovarian Cancer

$514,525
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2015 · CA

Protein Kinase Signaling in the Genotoxic Stress Response

$514,502
Michael B Yaffe · Massachusetts Institute Of Technology · R35 · FY2023 · ES

Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytes

$514,343
Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA

Project 1: Blood Immunomethylomic Markers of Outcome in Glioblastoma Patients

$514,271
John K. Wiencke · University Of California, San Francisco · P50 · FY2022 · CA

Project 1: Blood Immunomethylomic Markers of Outcome in Glioblastoma Patients

$514,270
John K. Wiencke · University Of California, San Francisco · P50 · FY2021 · CA

Organoid models of KRAS mutant cancer

$514,251
Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

The Kdm6a-dependent Sex Epigenome in Bladder Tumor Suppression

$514,028
Xue Sean Li · Cedars-Sinai Medical Center · P01 · FY2024 · CA

Effector T Cell Trafficking in Ovarian Cancer

$513,972
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2017 · CA

Effector T Cell Trafficking in Ovarian Cancer

$513,972
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2018 · CA

Effector T Cell Trafficking in Ovarian Cancer

$513,972
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2016 · CA

Mechanisms of cytokine driven tumor elicited inflammation in colorectal cancer

$513,939
Sergei I Grivennikov · Research Inst Of Fox Chase Can Ctr · R01 · FY2019 · CA

Role of metabolic crosstalk in determining immunity during tumor progression

$513,916
Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2023 · CA

Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids

$513,840
Chad A. Mirkin · Northwestern University · R01 · FY2025 · CA

Reversing immune evasion and enhancing immune detection with topical resiquimod

$513,783
Rachael Ann Clark · Brigham And Women'S Hospital · R01 · FY2018 · AR

Regulation of Mast Cell Proteases

$513,681
Richard L Stevens · Brigham And Women'S Hospital · P01 · FY2009 · HL

FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A

$513,659
Jindan Yu · Emory University · R01 · FY2025 · CA

The Role of the Amino Acid Hypusine in the Maintenance and Function of Tissue-Resident Macrophages

$513,643
Erika L Pearce · Johns Hopkins University · R01 · FY2024 · AI

Small molecule CXCR4 modulators as molecular probes for studying AML

$513,581
Gary E Schiltz · Northwestern University · R01 · FY2017 · CA

Tumor Microenvironment in Cancer Progression

$513,579
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis

$513,579
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Signal Transduction by Non-Transmembrane PTPs

$513,507
Benjamin G. Neel · New York University School Of Medicine · R01 · FY2019 · CA

Translational Pathology Core

$513,466
William Dean Wallace · University Of Southern California · P30 · FY2024 · CA

FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A

$513,441
Jindan Yu · Emory University · R01 · FY2023 · CA